Gene Bridges – 重组公司
使用Red / ET重组工程允许在任何选定位置克隆,亚克隆和修饰DNA。它允许设计任何大小的DNA分子,包括非常大的DNA分子,如BAC或大肠杆菌染色体。
红/ ET重组增加了CRISPR / Cas9的功效以扩展基因组研究。作为欧盟资助项目AgedBrainSYSBIO的一部分,我们制定了一项新的人类化大型基因组区域战略。通过将CRISPR / Cas9与Red / ET Recombineering组合,我们成功地将 33kb人片段敲入小鼠ApoE基因座。
4-Way Recombineering(4WR)提供了一种新的快速简化的方法,可在单个体内重组步骤中从多4个DNA片段(例如PCR产物)组装质粒。4WR是Gene Bridges广受欢迎的直接克隆 – 大肠杆菌菌株GB05-dir(目录号K008)的新应用。
Gene Bridges拥有Red / ET Recombination的专有权,并被允许颁发技术许可并提供重组工程服务。没有其他学术或商业组织有权提供重组工程服务。
genebridges2019年价格表
货号 | 品名 | 规格 | 价格 |
K001 | * Quick & Easy BAC Modification Kit | Kit | 13900 |
K002 | * Counter Selection BAC Modification Kit | Kit | 16400 |
K003 | * BAC Subcloning Kit | Kit | 13900 |
K004 | * Quick & Easy Conditional Knock Out Kit – FRT | Kit | 13900 |
K005 | * Quick & Easy Conditional Knock Out Kit – loxP | Kit | 13900 |
K006 | *Quick & Easy E.Coli Gene Deletion Kit | Kit | 13900 |
K008 | *Direct-cloning-proficient E.coli strain GB05-dir | Kit | 12400 |
K009 | *Recombineering-proficient E.coli strain GB08-red | Kit | 12400 |
A001 | Pro- and Eukaryotic Neomycin Selection Cassette (PGK-gb2-neo) | 50ng/ | 5980 |
A002 | FRT flanked, Pro and Euk. Neomycin Select. Cassette (FRT-PGK-gb2-neo-FRT) | 50ng/ | 5980 |
A003 | loxP flanked, Pro and Euk. Neomycin Select. Cassette (loxP-PGK-gb2-neo-loxP) | 50ng/ | 5980 |
A004 | FRT flanked, Pro and Euk. Neomycin Select. Cassette plus loxP site(FRT-PGK-gb2-neo-FRT-loxP) | 50ng/ | 5980 |
A005 | FRT flanked, Pro and Euk. Neomycin Select. Cassette plus loxP site 2nd version (loxP-FRT-PGK-gb2-neo-FRT) | 50ng/ | 5980 |
A006 | FRT flanked Chloramphenicol Select. Cassette (FRT-cm-FRT) | 50ng/ | 5980 |
A007 | loxP flanked Chloramphenicol Select. Cassette (loxP-cm-loxP) | 50ng/ | 5980 |
A008 | FRT flanked Ampicillin Select. Cassette (FRT-amp-FRT) | 50ng/ | 5980 |
A009 | loxP flanked Ampicillin Select. Cassette (loxP-amp-loxP) | 50ng/ | 5980 |
A010 | FRT flanked, Pro and Euk. Hygromycin Select. Cassette (FRT-PGK-gb2-hygro-FRT) | 50ng/ | 5980 |
A011 | loxP flanked, Pro and Euk. Hygromycin Select. Cassette (loxP-PGK-gb2-hygro-loxP) | 50ng/ | 5980 |
A012 | iCre-FRT-neo-FRT (codon improved Cre(iCre) with attached FRT flanked, Pro- and Eukaryotic Neomycin selection cassette | 50ng/ | 6500 |
A013 | iCreERT2-FRT-neo-FRT (ligand-inducible iCre with attached FRT flanked, Pro- and Eukaryotic Neomycin Selection cassette) | 50ng/ | 6500 |
A104 | Enhanced Flp Expression Plasmid:707-FLPe; tet | 0.2ug/ | 5980 |
A105 | Enhanced Flp Expression Plasmid:708-FLPe;cm | 0.2ug/ | 5980 |
A106 | Enhanced Flp Expression Plasmid:709-FLPe;amp | 0.2ug/ | 5980 |
A107 | Enhanced Flp Expression Plasmid:710-FLPe;km | 0.2ug/ | 5980 |
A112 | Cre Expression Plasmid:705-Cre;cm | 0.2ug/ | 5980 |
A113 | Cre Expression Plasmid:706-Cre;tet | 0.2ug/ | 5980 |
A114 | Cre Expression Plasmid:704-Cre;amp | 0.2ug/ | 5980 |
A201 | Enhanced Eukaryotic FLP Expression Plasmid: pCAGGS-FLPe (Academia) | 0.2ug/ | 7500 |
A203 | Eukaryotic FLPo Recombinase Expression Plasmid: pCAGGS-FLPo (Academia)* | 0.2ug/ | 7500 |
A204 | Eukaryotic Cre Recombinase Expression Plasmid: pCAGGS-Cre (Academia)* | 0.2ug/ | 7500 |
A205 | Eukaryotic Der Recombinase Expression Plasmid: CAGGS-Dre(Academia)* | 0.2ug/ | 7500 |
A301 | Arabinose-inducible Prokaryotic Cre Recombinase Expression Plasmid: pSC101-BAD-Cre | 0.2ug/ | 5980 |
A302 | Arabinose-inducible Prokaryotic Dre Recombinase Expression Plasmid: pSC101-BAD-Dre* | 0.2ug/ | 5980 |
A303 | Arabinose-inducible Prokaryotic FLPe Recombinase Expression Plasmid: pSC101-BAD-FLPe (tet) | 0.2ug/ | 5980 |